Cargando…

Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review

The World Health Organization classifies combined hormonal contraception as an unacceptable health risk in the presence of a known thrombogenic mutation but advises against routine thrombophilia screening before initiating combined oral contraceptives (COCs) on the grounds of high screening costs an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiedemann, Bridget, Vernon, Erin, Bowie, Bonnie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462992/ https://www.ncbi.nlm.nih.gov/pubmed/30650548 http://dx.doi.org/10.3390/jpm9010004

Ejemplares similares

Examining the use of oral contraceptives in the management of acne
por: Salvaggio, Heather L, et al.
Publicado: (2010)

Review of the literature on combined oral contraceptives and cancer
por: Kamani, Mustafa, et al.
Publicado: (2022)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Need for Screening Triglyceride Levels in Women on Oral Contraceptives
por: Yau, Alice, et al.
Publicado: (2021)

Oral Contraceptives and Breast Cancer
por: Kinlen, L.J.
Publicado: (1993)

Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013)

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
por: Satish, Sanjana, et al.
Publicado: (2023)

Examining the relation between oral contraceptive use and attentional engagement in everyday life
por: Smith, Alyssa C., et al.
Publicado: (2023)

Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle
por: Hampson, Elizabeth, et al.
Publicado: (2022)

Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
por: Hohmann, Heather
Publicado: (2009)

Evaluation of extended and continuous use oral contraceptives
por: Wright, Kristen Page, et al.
Publicado: (2008)

Clinical utility of folate-containing oral contraceptives
por: Lassi, Zohra S, et al.
Publicado: (2012)

RE-EXAMINING PATIENT-CENTERED CARE THROUGH DESIGN PROCESS
por: Mulhorn, Kristine, et al.
Publicado: (2022)

Combined Oral Contraceptives and Vascular Thrombosis: A Single-Center Experience
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach
por: Preethy, Senthilkumar, et al.
Publicado: (2023)

Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review
por: Tekle, Esayas, et al.
Publicado: (2022)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Oral contraceptives and breast cancer.
por: Jick, S. S., et al.
Publicado: (1989)

Use of Combined Oral Contraceptives in Perimenopausal Women
por: Cho, Moon Kyoung
Publicado: (2018)

Hepatocellular carcinoma and oral contraceptives.
por: Henderson, B. E., et al.
Publicado: (1983)

Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013)

Re-examination of the standardization of colon cancer surgery
por: Yao, Hong-wei, et al.
Publicado: (2013)

Re: Repair Index in Examination of Nuclear Changes in the Buccal Mucosa of Smokers: A Useful Method for Screening of Oral Cancer
por: Nersesyan, Armen
Publicado: (2019)

Oral contraceptives alter oral health
por: Saini, Rajiv, et al.
Publicado: (2010)

Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014)

The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
por: Vredevoogd, D.W., et al.
Publicado: (2021)

Effects of orally administered hormonal contraceptives on the musculoskeletal system of healthy premenopausal women—A systematic review
por: Römer, Claudia, et al.
Publicado: (2022)

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
por: Zimmerman, Y., et al.
Publicado: (2014)

Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians
por: Nappi, Rossella E., et al.
Publicado: (2016)

Iron-Containing Oral Contraceptives and Their Effect on Hemoglobin and Biomarkers of Iron Status: A Narrative Review
por: Fischer, Jordie A. J., et al.
Publicado: (2021)

Re-Examining the Role of TNF in MS Pathogenesis and Therapy
por: Fresegna, Diego, et al.
Publicado: (2020)

Oral contraceptives and breast cancer.
por: Asscher, A. W.
Publicado: (1987)

Malignant melanoma and oral contraceptives
por: Kay, C. R.
Publicado: (1981)

Oral contraceptives and breast cancer.
por: Chilvers, C. E., et al.
Publicado: (1990)

Oral contraceptives and malignant melanoma.
por: Hannaford, P. C., et al.
Publicado: (1991)

The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis
por: Elliott-Sale, Kirsty J., et al.
Publicado: (2020)

Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing(®))
por: Wieder, Devorah R, et al.
Publicado: (2010)

Oral contraceptives and colorectal cancer risk - A meta-analysis and systematic review
por: Abusal, Fadi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sge1t9stshpm2mhrcrtgota8rr